Apimeds Pharmaceuticals US, Inc. (APUS)

Every official Apimeds Pharmaceuticals US, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Apimeds Pharmaceuticals US, Inc. documents

• Apimeds Pharmaceuticals US, Inc. 10-K 2026APUS 10-K 2026: annual report for fiscal 2026
• Apimeds Pharmaceuticals US, Inc. 10-K 2025APUS 10-K 2025: annual report for fiscal 2025
• Apimeds Pharmaceuticals US, Inc. 10-K 2024APUS 10-K 2024: annual report for fiscal 2024
• Apimeds Pharmaceuticals US, Inc. 10-K 2023APUS 10-K 2023: annual report for fiscal 2023
• Apimeds Pharmaceuticals US, Inc. 10-K 2022APUS 10-K 2022: annual report for fiscal 2022
• Apimeds Pharmaceuticals US, Inc. 10-Q 2026APUS 10-Q 2026: quarterly report for fiscal 2026
• Apimeds Pharmaceuticals US, Inc. 10-Q 2025APUS 10-Q 2025: quarterly report for fiscal 2025
• Apimeds Pharmaceuticals US, Inc. 10-Q 2024APUS 10-Q 2024: quarterly report for fiscal 2024
• Apimeds Pharmaceuticals US, Inc. 10-Q 2023APUS 10-Q 2023: quarterly report for fiscal 2023
• Apimeds Pharmaceuticals US, Inc. 10-Q 2022APUS 10-Q 2022: quarterly report for fiscal 2022
• Apimeds Pharmaceuticals US, Inc. 8-K 2026APUS 8-K 2026: current report for fiscal 2026
• Apimeds Pharmaceuticals US, Inc. 8-K 2025APUS 8-K 2025: current report for fiscal 2025
• Apimeds Pharmaceuticals US, Inc. 8-K 2024APUS 8-K 2024: current report for fiscal 2024
• Apimeds Pharmaceuticals US, Inc. 8-K 2023APUS 8-K 2023: current report for fiscal 2023
• Apimeds Pharmaceuticals US, Inc. 8-K 2022APUS 8-K 2022: current report for fiscal 2022
• Apimeds Pharmaceuticals US, Inc. DEF 14A 2026APUS DEF 14A 2026: proxy statement for fiscal 2026
• Apimeds Pharmaceuticals US, Inc. DEF 14A 2025APUS DEF 14A 2025: proxy statement for fiscal 2025
• Apimeds Pharmaceuticals US, Inc. DEF 14A 2024APUS DEF 14A 2024: proxy statement for fiscal 2024
• Apimeds Pharmaceuticals US, Inc. DEF 14A 2023APUS DEF 14A 2023: proxy statement for fiscal 2023
• Apimeds Pharmaceuticals US, Inc. DEF 14A 2022APUS DEF 14A 2022: proxy statement for fiscal 2022
• Apimeds Pharmaceuticals US, Inc. Form 4 2026APUS Form 4 2026: insider trading filing for fiscal 2026
• Apimeds Pharmaceuticals US, Inc. Form 4 2025APUS Form 4 2025: insider trading filing for fiscal 2025
• Apimeds Pharmaceuticals US, Inc. Form 4 2024APUS Form 4 2024: insider trading filing for fiscal 2024
• Apimeds Pharmaceuticals US, Inc. Form 4 2023APUS Form 4 2023: insider trading filing for fiscal 2023
• Apimeds Pharmaceuticals US, Inc. Form 4 2022APUS Form 4 2022: insider trading filing for fiscal 2022
• Apimeds Pharmaceuticals US, Inc. S-1 2026APUS S-1 2026: registration statement for fiscal 2026
• Apimeds Pharmaceuticals US, Inc. S-1 2025APUS S-1 2025: registration statement for fiscal 2025
• Apimeds Pharmaceuticals US, Inc. S-1 2024APUS S-1 2024: registration statement for fiscal 2024
• Apimeds Pharmaceuticals US, Inc. S-1 2023APUS S-1 2023: registration statement for fiscal 2023
• Apimeds Pharmaceuticals US, Inc. S-1 2022APUS S-1 2022: registration statement for fiscal 2022
• Apimeds Pharmaceuticals US, Inc. 13F 2026APUS 13F 2026: institutional holdings for fiscal 2026
• Apimeds Pharmaceuticals US, Inc. 13F 2025APUS 13F 2025: institutional holdings for fiscal 2025
• Apimeds Pharmaceuticals US, Inc. 13F 2024APUS 13F 2024: institutional holdings for fiscal 2024
• Apimeds Pharmaceuticals US, Inc. 13F 2023APUS 13F 2023: institutional holdings for fiscal 2023
• Apimeds Pharmaceuticals US, Inc. 13F 2022APUS 13F 2022: institutional holdings for fiscal 2022

More companies